Psychiatry and Neurology, Neurology · Indianapolis, IN
NPI
1033132097
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
550 University Blvd
Indianapolis, IN, 46202
Phone (317) 274-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
144 services
Medicare patients, 2024
85
Average age 61
Drug cost, 2024
$587K
1,934 prescriptions
Company payments, 2025
$56K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vicenta Salanova was code 99215 (office e&m - established), 60 times for 44 patients. In total Vicenta Salanova billed 144 services in 16 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 60 | 44 | $102.21 | $6,133 |
| 95720 Neurologic | Facility | 26 | 17 | $150.56 | $3,914 |
By year: 2022 $22K for 227 services; 2023 $21K for 201 services; 2024 $14K for 144 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vicenta Salanova prescribed most often to Medicare patients was Lacosamide, with 370 prescriptions and refills. In total Vicenta Salanova wrote 1,934 Medicare prescriptions that cost $587K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 370 | 516 | 48 | $41K |
| Lamotrigine Generic | 291 | 547 | 38 | $4,567 |
| Levetiracetam Generic | 273 | 600 | 61 | $15K |
| Oxcarbazepine Generic | 106 | 200 | 19 | $13K |
| Topiramate Generic | 94 | 192 | 17 | $1,876 |
| Clobazam Generic | 76 | 100 | 13 | $7,826 |
| Phenytoin Sodium Extended Generic | 51 | 109 | 11 | $1,361 |
| Briviact Brivaracetam | 51 | 59 | Under 11 | $111K |
| Divalproex Sodium Er Divalproex Sodium | 49 | 90 | Under 11 | $3,843 |
| Divalproex Sodium Generic | 44 | 88 | Under 11 | $3,211 |
| Vimpat Lacosamide | 39 | 47 | Under 11 | $52K |
| Gabapentin Generic | 37 | 71 | 11 | $1,380 |
| Lorazepam Generic | 36 | 44 | Under 11 | $171 |
| Pregabalin Generic | 32 | 78 | Under 11 | $1,953 |
| Carbamazepine Generic | 30 | 58 | Under 11 | $2,688 |
Brand drugs: - claims; generic drugs: 1,688 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vicenta Salanova $56K (- in general payments such as food, travel and fees and $56K for research) from 2 companies. The largest payer was Neuropace, Inc. with $56K.
| Company | Payments | Amount |
|---|---|---|
| Neuropace, Inc. NPCE | 95 | $56K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.